Back

Which stent wins? Nationwide insights on drug-eluting vs. non-drug-eluting stents in prostate cancer patients undergoing PCI

23 April 2026 (08:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Heterogeneity of vascular and atherosclerotic risk phenotypes Revascularisation Delegates Premium Access ESC Preventive Cardiology 2026 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Vagisha Sharma

Guthrie Clinic, Sayre (United States of America)

4 More presentations in this session

Presentation thumbnail
Prognostic impact of total physiologic atherosclerotic burden and residual cholesterol risk in statin-treated patients undergoing PCI
Miss H. Sze (Hong Kong, HK)
Abstract Slides
Presentation thumbnail
Diagnostic role of aortic valve calcium scoring in aortic stenosis according to etiology
Doctor E. Shirka (Tirana, AL)
Presentation thumbnail
Effect of the ugt1a3*2 haplotype on pharmacokinetics and pharmacodynamics of atorvastatin in patients with coronary heart disease
Ms A. Uduma (Oslo, NO)
Abstract Slides
Presentation thumbnail
Efficacy of colchicine in reducing cardiovascular events in patients with low-to-normal LDL-C levels
Mrs T. Shengelia (Tbilisi, GE)
Abstract Slides

Access the full session

Session thumbnail
Heterogeneity of vascular and atherosclerotic risk phenotypes

The Event

Event poster

ESC Preventive Cardiology 2026

23 April - 25 April 2026

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources